HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | A207804 | PRINSTON PHARMACEUTICAL INC
Highest NADAC/Unit
$0.2379
per ea
Lowest NADAC/Unit
$0.1817
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 43547039203OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB | $0.2379 | EA | Generic | — | 2026-06-17 |
| 43547039209OLMESARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TAB | $0.2379 | EA | Generic | — | 2026-06-17 |
| 43547039303OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB | $0.2317 | EA | Generic | — | 2026-06-17 |
| 43547039309OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB | $0.2317 | EA | Generic | — | 2026-06-17 |
| 43547039103OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | $0.1817 | EA | Generic | — | 2026-06-17 |
| 43547039109OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | $0.1817 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.